SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Omega Protein Corp. To Contact The Firm Before Lead Plaintiff Deadline

NEW YORK, April 17, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Omega Protein Corp. ("Omega" or the "Company") (NYSE:OME) of the May 1, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.

The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Omega stock or options between June 4, 2013 and March 1, 2017 (the "Class Period").  The case, Malone v. Omega Protein Corporation et al, No. 17-cv-01596 was filed on March 2, 2017, and has been assigned to Judge P. Kevin Castel.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by engaging in conduct that would potentially lead to an investigation into its whistleblower policy by the U.S. Securities and Exchange Commission ("SEC")

Specifically, on March 1, 2017, the Company acknowledged that the SEC issued a subpoena in December 2016 requesting information in connection with an investigation relating to a Company subsidiary's compliance with its probation terms and the Company's protection of whistleblower employees.

After the announcement, Omega's share price fell from $26.25 per share on March 1, 2017 to a closing price of $20.00 on March 2, 2017—a $6.25 or a 23.8% drop.

Request more information now by clicking here: www.faruqilaw.com/OME. There is no cost or obligation to you.

Take Action

If you invested in Omega stock or options between June 4, 2013 and March 1, 2017 and would like to discuss your legal rights, visit www.faruqilaw.com/OME. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Omega's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class that is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. 

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
685 Third Avenue, 26^th Floor
New York, NY 10017
Attn:  Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-in-excess-of-100000-investing-in-omega-protein-corp-to-contact-the-firm-before-lead-plaintiff-deadline-300440404.html

SOURCE Faruqi & Faruqi, LLP